Abstract

Bacteria that are resistant to antimicrobial agents, which were previously isolated primarily in acute-care hospitals, now cause infection in a wide range of other healthcare settings. Improved detection of new resistant strains — especially by using practical and affordable screening methods and by evaluating mechanisms of resistance — is a priority for tackling this problem effectively. Standardized, effective surveillance systems for evaluating the emergence and prevalence of resistant strains are necessary to assess the success of intervention strategies.

Author affiliations

1. John E. McGowan Jr is at the Department of Epidemiology, Rollins School of Public Health of Emory University, 1518 Clifton Road, Atlanta, Georgia 30322, USA.
2. Fred C. Tenover is at the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, Georgia 30333, USA.

Correspondence to: John E. McGowan, Jr¹ Email: jmcgowa@sph.emory.edu

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.